Cargando…
Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19
[Image: see text] COVID-19 is a biphasic infectious disease with no approved vaccine or pharmacotherapy. The first drug that has shown promise in reducing COVID-19 mortality in severely-ill patients is dexamethasone, a cheap, well-known anti-inflammatory glucocorticoid, approved for the treatment of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American
Chemical Society
2020
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689662/ https://www.ncbi.nlm.nih.gov/pubmed/33251412 http://dx.doi.org/10.1021/acsomega.0c03597 |